Global Tumor Ablation and Interventional Radiology Market Growth (Status and Outlook) 2025-2031

According to this study, the global Tumor Ablation and Interventional Radiology market size will reach US$ million by 2031.

An interventional radiologist uses ultrasound, CT, or both to guide specialized needles into the tumor. The needles use heat (microwave or radiofrequency ablation), cold (cryoablation), or rapid-pulsed electricity (irreversible electroporation) to kill the tumor without requiring open surgery.

United States market for Tumor Ablation and Interventional Radiology is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Tumor Ablation and Interventional Radiology is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Tumor Ablation and Interventional Radiology is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Tumor Ablation and Interventional Radiology players cover Angiodynamics, Medtronic, Boston Scientific, Galil Medical, Neuwave Medical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Tumor Ablation and Interventional Radiology Industry Forecast” looks at past sales and reviews total world Tumor Ablation and Interventional Radiology sales in 2024, providing a comprehensive analysis by region and market sector of projected Tumor Ablation and Interventional Radiology sales for 2025 through 2031. With Tumor Ablation and Interventional Radiology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tumor Ablation and Interventional Radiology industry.

This Insight Report provides a comprehensive analysis of the global Tumor Ablation and Interventional Radiology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Tumor Ablation and Interventional Radiology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tumor Ablation and Interventional Radiology market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tumor Ablation and Interventional Radiology and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tumor Ablation and Interventional Radiology.

This report presents a comprehensive overview, market shares, and growth opportunities of Tumor Ablation and Interventional Radiology market by product type, application, key players and key regions and countries.

Segmentation by Type:
Tumor Ablation
Interventional Radiology

Segmentation by Application:
Liver Cancer
Lung Cancer
Kidney Cancer
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Angiodynamics
Medtronic
Boston Scientific
Galil Medical
Neuwave Medical
Misonix
Merit Medical
Sonacare Medical
EDAP TMS

Please note: The report will take approximately 2 business days to prepare and deliver. Show more